Nexthera Capital LP — Q4 2018 13F 持股

Name: Nexthera Capital LP — 13F Holdings, Q4 2018
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001646343

申报总市值

US$1.2亿

← 返回最新季度

本季完整持股清单

#	代码	标的名称	资产子类别	占比	占比变动	持仓量变化
1	XBI	Ss Spdr S&p Biotech ETF	ETF-科技型	14.76%	—	-50.08%
2	BMRN	Biomarin Pharmaceutical INC	股票-医疗保健	11.98%	-0.89%	EXIT
3	NVS	Novartis Ag-sponsored Adr	股票-医疗保健	11.18%	-4.65%	EXIT
4	TEVA	Teva Pharmaceutical-sp Adr	股票-医疗保健	10.70%	—	—
5	HRTX	Heron Therapeutics INC	股票-其他	8.76%	-11.53%	EXIT
6	BOLDEUR	Audentes Therapeutics INC	股票-其他	6.72%	-2.60%	+41.21%
7	IMMU	Immunomedics INC	股票-其他	5.26%	-1.74%	-36.03%
8	BHC	Bausch Health Cos INC	股票-医疗保健	5.06%	-6.16%	EXIT
9	INSM	Insmed INC	股票-医疗保健	4.54%	+0.01%	+17.47%
10	GBTUSD	Global Blood Therapeutics In	股票-其他	3.75%	+0.64%	-59.64%
11	✓	Horizon Pharma PLC	股票-其他	3.19%	—	—
12	STMLEUR	Stemline Therapeutics INC	股票-其他	2.79%	-5.08%	EXIT
13	EXEL	Exelixis INC	股票-医疗保健	2.49%	-2.61%	EXIT
14	CBAYUSD	Cymabay Therapeutics INC	股票-其他	2.32%	-3.39%	EXIT
15	CHMA	Chiasma INC	股票-其他	1.37%	-1.29%	EXIT
16	✓	Gyre Therapeutics INC Com	股票-其他	1.22%	—	-57.87%
17	DCPHEUR	Deciphera Pharmaceuticals In	股票-其他	1.05%	-1.21%	EXIT
18	STRO	Sutro Biopharma, Inc.	股票-其他	0.93%	—	+7.72%
19	ZSANEUR	Zosano Pharma CORP	股票-其他	0.70%	—	-22.74%
20	ATNXEUR	Athenex INC	股票-其他	0.65%	—	—
21	✓	Rvl Pharmaceuticals PLC	股票-其他	0.39%	—	—
22	✓	Mediwound LTD	股票-其他	0.17%	—	-39.60%
23	✓		股票-其他	0.03%	—	—

本季持股变动

Nexthera Capital LP 于截至 Q4 2018 该季申报之持仓异动，含代码、发行人、权重变化、股数变化与操作类型
#	代码	标的名称	占比变动	持仓量变化	异动类型
1	HRTX	Heron Therapeutics INC	+8.2%	+811.71%	加仓
2	BOLDEUR	Audentes Therapeutics INC	+2.6%	+41.21%	加仓
3	BHC	Bausch Health Cos INC	+2.4%	+21.88%	加仓
4	INSM	Insmed INC	+1.8%	+17.47%	加仓
5	STMLEUR	Stemline Therapeutics INC	+0.9%	+22.25%	加仓
6	CHMA	Chiasma INC	+0.9%	+67.51%	加仓
7	DCPHEUR	Deciphera Pharmaceuticals In	+0.8%	+298.05%	加仓
8	CBAYUSD	Cymabay Therapeutics INC	+0.4%	-21.34%	减仓
9	STRO	Sutro Biopharma, Inc.	+0.3%	+7.72%	加仓
10	ZSANEUR	Zosano Pharma CORP	-0.1%	-22.74%	减仓
11	GBTUSD	Global Blood Therapeutics In	-0.3%	-59.64%	减仓
12	IMMU	Immunomedics INC	-0.3%	-36.03%	减仓
13	✓	Gyre Therapeutics INC Com	-0.6%	-57.87%	减仓
14	EXEL	Exelixis INC	-3.4%	-82.26%	减仓
15	XBI	Ss Spdr S&p Biotech ETF	-3.6%	-50.08%	减仓
16	✓		—	EXIT	清仓
17	NVS	Novartis Ag-sponsored Adr	—	NEW	新建仓
18	TEVA	Teva Pharmaceutical-sp Adr	—	NEW	新建仓
19	✓	Mylan N V	—	EXIT	清仓
20	DOVA	Dova Pharmaceuticals INC	—	EXIT	清仓
21	CARAEUR	Cara Therapeutics INC	—	EXIT	清仓
22	✓	Endocyte INC	—	EXIT	清仓
23	ACAD	Acadia Pharmaceuticals INC	—	EXIT	清仓
24	ABEO1EUR	Abeona Therapeutics INC	—	EXIT	清仓
25	ARQLUSD	Arqule INC	—	EXIT	清仓
26	TXMDEUR	Therapeuticsmd INC	—	EXIT	清仓
27	NKTREUR	Nektar Therapeutics	—	EXIT	清仓
28	✓	Horizon Pharma PLC	—	NEW	新建仓
29	AZNN	Astrazeneca Plc-spons Adr	—	EXIT	清仓
30	ACHNEUR	Achillion Pharmaceuticals	—	EXIT	清仓
31	VKTX	Viking Therapeutics INC	—	EXIT	清仓
32	KURA	Kura Oncology INC	—	EXIT	清仓
33	LLY	Eli Lilly & Co	—	EXIT	清仓
34	PFE	Pfizer INC	—	EXIT	清仓
35	✓	Foamix Pharmaceuticals LTD	—	EXIT	清仓
36	IOVA	Iovance Biotherapeutics INC	—	EXIT	清仓
37	FGENEUR	Fibrogen INC	—	EXIT	清仓
38	✓		—	EXIT	清仓
39	TGTX	Tg Therapeutics INC	—	EXIT	清仓
40	✓	Oncosec Medical	—	EXIT	清仓
41	✓	Magenta Therapeutics INC	—	EXIT	清仓
42	ATNXEUR	Athenex INC	—	NEW	新建仓
43	NEOS	Neos Therapeutics INC	—	EXIT	清仓
44	✓	Oncomed Pharmaceuticals INC	—	EXIT	清仓
45	✓	Synergy Pharmaceuticals Inc.	—	EXIT	清仓
46	CLSDUSD	Clearside Biomedical INC	—	EXIT	清仓
47	SVRA	Savara INC	—	EXIT	清仓
48	✓	Proqr Thrapeutics N V	—	EXIT	清仓
49	ADAPY	Adaptimmune Therapeutics-adr	—	EXIT	清仓
50	✓	Acorda Therapeutics INC	—	EXIT	清仓